Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for BioHarvest Sciences Inc. (BHST : NSDQ)

• Company Description    BioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada. Number of Employees: 89

• Price / Volume Information    Yesterday's Closing Price: $1.92 Daily Weekly Monthly 20 Day Moving Average: 40,984 shares Shares Outstanding: 19.62 (millions) Market Capitalization: $37.66 (millions) Beta: 0.87 52 Week High: $12.80 52 Week Low: $1.82 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -30.18% -30.70% 12 Week -54.39% -55.64% Year To Date -63.01% -64.39%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1140 - 625 HOWE STREET - VANCOUVER,A1 V6C 2T6 CAN ph: 604-622-1186 fax: - justin@bioharvest.com https://bioharvest.com

• General Corporate Information    Officers Ilan Sobel - Chief Executive Officer Zaki Rakib - Chairman Ilana Belzer - Chief Operating Officer Bar Dichter - Chief Financial Officer Malkit Azachi - Vice-President Peer Information BioHarvest Sciences Inc. (CORR.) BioHarvest Sciences Inc. (RSPI) BioHarvest Sciences Inc. (CGXP) BioHarvest Sciences Inc. (BGEN) BioHarvest Sciences Inc. (GTBP) BioHarvest Sciences Inc. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 09076J207 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/10/26 Share - Related Items Shares Outstanding: 19.62 Most Recent Split Date: 6.00 (0.03:1) Beta: 0.87 Market Capitalization: $37.66 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.11 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.44 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/10/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.64 Price/Cash Flow: - Price / Sales: 1.07 EPS Growth vs. Year Ago Period: 15.38% vs. Previous Quarter: -10.00% Sales Growth vs. Year Ago Period: 8.23% vs. Previous Quarter: -6.17% ROE 06/30/26 - - 03/31/26 - -76.03 12/31/25 - -136.42 ROA 06/30/26 - - 03/31/26 - -25.30 12/31/25 - -27.92 Current Ratio 06/30/26 - - 03/31/26 - 2.96 12/31/25 - 3.97 Quick Ratio 06/30/26 - - 03/31/26 - 2.44 12/31/25 - 3.38 Operating Margin 06/30/26 - - 03/31/26 - -28.11 12/31/25 - -27.76 Net Margin 06/30/26 - - 03/31/26 - -32.54 12/31/25 - -32.27 Pre-Tax Margin 06/30/26 - - 03/31/26 - -32.30 12/31/25 - -32.05 Book Value 06/30/26 - - 03/31/26 - 1.17 12/31/25 - 1.30 Inventory Turnover 06/30/26 - - 03/31/26 - 3.15 12/31/25 - 3.28 Debt-to-Equity 06/30/26 - - 03/31/26 - 0.03 12/31/25 - 0.10 Debt-to-Capital 06/30/26 - - 03/31/26 - 3.30 12/31/25 - 8.68

Powered by Zacks Investment Research ©